Hyperlipidemia in acute hemolysis
- PMID: 1942954
- DOI: 10.1007/BF01666827
Hyperlipidemia in acute hemolysis
Abstract
In 27 (78%) of 36 patients with massive hemolysis (defined as a fall in hematocrit of more than 12% within 12 h due to intravascular red cell destruction), hypertriglyceridemia (plasma triglycerides greater than 175 mg/dl) was present or appeared within two days after the hemolytic crisis. Eighteen subjects with triglycerides exceeding 300 mg/dl (peak 516 +/- 39 mg/dl) were further analyzed. The development of hyperlipidemia was independent of the etiology of hemolysis (microangiopathic hemolytic disease 7, toxicemia 3, parainfectious complications 3, autoimmune hemolysis 2, glucose-6-phosphate dehydrogenase deficiency 2). Factors known to increase plasma triglycerides, such as shock, infections, or pancreatitis, were present in only a few cases. Hemolysis-associated complications were activation of intravascular coagulation (16), coma (13), acute renal failure (13), and respiratory insufficiency (5), organ dysfunctions indicating diffuse microvascular injury. Plasma triglycerides fell within a few days if the cause of red cell destruction was eliminated. In 5 of the 8 patients presenting with triglycerides below 175 mg/dl, severe hepatic dysfunction was present. We conclude that hemolysis causes transient hyperlipidemia, either directly by red cell destruction or indirectly by inducing intravascular coagulation, and possibly due to both increased triglyceride synthesis and decreased catabolism.
Similar articles
-
Pancreatitis in acute hemolysis.Ann Hematol. 1991 Jul;63(1):39-41. doi: 10.1007/BF01714959. Ann Hematol. 1991. PMID: 1715192
-
Intravascular stents do not cause microangiopathic hemolysis or thrombotic microangiopathy.J Clin Apher. 1999;14(3):130-4. doi: 10.1002/(sici)1098-1101(1999)14:3<130::aid-jca5>3.0.co;2-9. J Clin Apher. 1999. PMID: 10540368 Clinical Trial.
-
Insulin-dependent diabetes mellitus showing microangiopathic hemolytic anemia and chronic disseminated intravascular coagulation.Intern Med. 1992 Nov;31(11):1310-2. doi: 10.2169/internalmedicine.31.1310. Intern Med. 1992. PMID: 1295630
-
Hemolytic anemia.Am Fam Physician. 2004 Jun 1;69(11):2599-606. Am Fam Physician. 2004. PMID: 15202694 Review.
-
Microangiopathic hemolytic anemia as the initial manifestation of porcine valve failure.South Med J. 1990 Aug;83(8):912-7. doi: 10.1097/00007611-199008000-00015. South Med J. 1990. PMID: 2200135 Review.
Cited by
-
Haemolysis as Influence & Interference Factor.EJIFCC. 2002 Jun 10;13(4):95-98. eCollection 2002 Jun. EJIFCC. 2002. PMID: 30386190 Free PMC article. No abstract available.
-
Hypertriglyceridemia Causing Continuous Renal Replacement Therapy Dysfunction in a Patient with End-stage Liver Disease.Indian J Nephrol. 2018 Jul-Aug;28(4):303-306. doi: 10.4103/ijn.IJN_201_17. Indian J Nephrol. 2018. PMID: 30158750 Free PMC article.
-
Hypertriglyceridemia Thalassemia Syndrome: Common Disease, Uncommon Association.Indian J Pediatr. 2016 Jul;83(7):720-2. doi: 10.1007/s12098-016-2062-x. Epub 2016 Mar 3. Indian J Pediatr. 2016. PMID: 26935201
-
Hemolisis Como Influencia Y Factor de Interferencia.EJIFCC. 2002 Jun 10;13(4):107-113. eCollection 2002 Jun. EJIFCC. 2002. PMID: 30386192 Free PMC article. Spanish. No abstract available.
-
Autoimmune pancreatitis with concomitant autoimmune haemolytic anaemia.BMJ Case Rep. 2018 Mar 23;2018:bcr2018224280. doi: 10.1136/bcr-2018-224280. BMJ Case Rep. 2018. PMID: 29574435 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Medical